{"id":"bd53a1a8-e9ff-4f4f-aa38-e101d416f599","modelId":"531efadb-fc98-42ca-872f-7d7957006641","versionId":null,"locationId":"42e3232e-0aad-4cf2-96d5-903138532030","operatorId":null,"ownerId":null,"slug":"brainq-medstar-nrh-washington-dc","status":"operational","firstSeen":"2021-12-09T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":null,"shiftStructure":null,"hoursPerDay":null,"siteType":null,"operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":null,"deploymentScale":null,"siteEnvironment":null,"operatorType":null,"sourceQualityTier":null,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.prnewswire.com/il/news-releases/first-patient-enrolled-in-brainqs-pivotal-trial-emagine-301441414.html","name":"PR Newswire","title":"First Patient Enrolled in BrainQ Pivotal Trial EMAGINE"}],"notes":"MedStar National Rehabilitation Hospital — first site to enroll patient in BrainQ pivotal EMAGINE trial Dec 9, 2021. Frequency-tuned electromagnetic field therapy for ischemic stroke. Up to 150 subjects across 19 sites.","keyFacts":[],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":null,"scaleTier":null,"contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-08-12T23:18:16.322Z","updatedAt":"2026-08-12T23:18:16.707Z","model":{"id":"531efadb-fc98-42ca-872f-7d7957006641","companyId":"76cbc9a5-8f6d-42be-916f-88344289b6ef","modelName":"BrainQ Non-Invasive BCI","slug":"brainq-neuro-device","description":"AI-powered non-invasive electromagnetic neurorecovery device for stroke rehabilitation.","formFactor":"biometric","industryVertical":"healthcare","environment":"indoor","maturityStage":"pilot","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://brainqtech.com/","title":"BRAIN.Q: AI-Powered Noninvasive Solution for Stroke Recovery","sourceName":"BrainQ"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[],"createdAt":"2026-08-08T22:32:38.254Z","updatedAt":"2026-08-09T03:57:34.330Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"76cbc9a5-8f6d-42be-916f-88344289b6ef","name":"BrainQ","slug":"brainq","description":"BrainQ is an Israeli neurotechnology company developing AI-powered, non-invasive electromagnetic therapy for stroke recovery. Its [BrainQ BCI](/models/brainq-non-invasive-bci) device delivers frequency-tuned electromagnetic stimulation to enhance brain recovery after ischemic stroke. The EMAGINE pivotal trial is enrolling 150 patients across 20 US clinical sites.","status":null,"founded":null,"hq":"Israel","hqLat":null,"hqLng":null,"hqGeocodedAt":null,"hqAddress":null,"hqPrecision":null,"website":"brainqtech.com","fundingTotal":null,"type":"both","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://brainqtech.com/","title":"BRAIN.Q: AI-Powered Noninvasive Solution for Stroke Recovery","sourceName":"BrainQ"}],"keyFacts":[{"label":"FDA","value":"Breakthrough Device Designation"},{"label":"Type","value":"Non-invasive electromagnetic"},{"label":"Indication","value":"Stroke recovery"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-08-08T22:32:37.870Z","updatedAt":"2026-08-08T22:39:07.258Z"}},"version":null,"location":{"id":"42e3232e-0aad-4cf2-96d5-903138532030","name":"Washington, DC, USA","slug":"washington-dc-usa-3","kind":"hospital","parentLocationId":null,"region":null,"lat":null,"lng":null,"reviewStatus":"unreviewed","aliases":[],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-08-12T23:18:15.941Z","updatedAt":"2026-08-12T23:18:15.941Z"},"operator":null,"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/brainq-medstar-nrh-washington-dc","url":"https://registry.deploy.report/deployments/brainq-medstar-nrh-washington-dc","name":"BrainQ Non-Invasive BCI at Washington, DC, USA","identifier":"bd53a1a8-e9ff-4f4f-aa38-e101d416f599","startDate":"2021-12-09T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/washington-dc-usa-3","name":"Washington, DC, USA"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/brainq","name":"BrainQ"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/brainq-neuro-device","name":"BrainQ Non-Invasive BCI"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"pilot","lifecycle_state":"active","architectural_position":{"cohort":"biometric","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}